$2.55
-0.05 (-1.92%)

Key Metrics

Market Cap
$6.43M
P/E Ratio
-0.56
EPS
$-4.52
Beta
N/A
Dividend Yield
N/A
ROE
-505.05%
Current Ratio
0.00

Company Information

Industry
Biotechnology

About Imunon Inc

Imunon Inc a clinical stage biotechnology company focuses on the development and commercialization of DNAbased immunotherapies vaccines and directed chemotherapies Its product pipeline includes GEN1 a DNAbased immunotherapy for the localized treatment of ovarian cancer and ThermoDox a proprietary heatactivated liposomal encapsulation of doxorubicin which is in development stage for various cancer indications The company also has two feasibility stage platform technologies for the development of nucleic acidbased immunotherapies vaccines and other anticancer DNA or RNA therapies The company was formerly known as Celsion Corporation and changed its name to Imunon Inc in September 2022 Imunon Inc was founded in 1982 and is based in Lawrenceville New Jersey

Recent Earnings Surprises

Date Actual EPS Estimated EPS Surprise
2026-05-12 $-0.84 $-1.22 +-30.9%
2026-03-31 $-1.29 $-1.43 +-9.8%
2025-11-13 $-1.16 $-1.73 +-32.9%
2025-08-05 $-1.87 $-3.09 +-39.5%

Financial Ratios (TTM)

Gross Margin
0.00%
Operating Margin
0.00%
Net Margin
0.00%
ROA
0.00%
Price to Book
0.00
Price to Sales
0.00